Abstract
AbstractPerinatal mood and anxiety disorders (PMADs), perinatal substance use disorders (PSUDs), and intimate partner violence (IPV) are leading causes of pregnancy-related deaths in the United States. Screening and referral for PMADs, PSUDs and IPV is recommended, however, racial disparities are prominent: Black pregnant and postpartum people (PPP) are less likely to be screened and attend treatment compared to White PPP. We conducted qualitative interviews to better understand the experience of Black PPP who used a text/phone-based screening and referral program for PMADs/PSUDs and IPV—Listening to Women and Pregnant and Postpartum People (LTWP). We previously demonstrated that LTWP led to a significant reduction in racial disparities compared to in-person screening and referral, and through the current study, sought to identify facilitators of PMAD/PSUD symptom endorsement and treatment attendance. Semi-structured interviews were conducted with 68 Black PPP who were or had been pregnant within the last 24 months, and who either had or did not have a PMAD or PSUD. Participants were enrolled in LTWP and provided feedback on their experience. Using a grounded theory approach, four themes emerged: usability, comfort, necessity, and recommendations. Ease of use, brevity, convenience, and comfort in discussing mental health and substance use via text were highlighted. Need for a program like LTWP in Black communities was discussed, given the reduction in perceived judgement and access to trusted information and resources for PMADs/PSUDs, which may lessen stigma. These qualitative findings illuminate how technology-based adaptations to behavioral health screening and referral can reduce perceived negative judgment and facilitate identification and referral to treatment, thereby more adequately meeting needs of Black PPP.
Funder
Medical University of South Carolina
Publisher
Springer Science and Business Media LLC
Reference96 articles.
1. UNICEF, UNFPA, World Bank Group and UNDESA/Population Division,. Trends in maternal mortality 2000 to 2020: estimates by WHO. Geneva, executive summary licence: CC BY-NC-SA 3.0 IGO. World Health Organization; 2023.
2. Hoyert D. Maternal mortality rates in the United States, 2020, National Center for Health Statistics (U.S.), Feb. 2022. https://doi.org/10.15620/cdc:113967.
3. Han B, Compton WM, Einstein EB, Elder E, Volkow ND. Pregnancy and postpartum drug overdose deaths in the US before and during the COVID-19 pandemic. JAMA Psychiatry. Nov. 2023. https://doi.org/10.1001/jamapsychiatry.2023.4523.
4. Fleszar LG, et al. Trends in state-level maternal mortality by racial and ethnic group in the United States. JAMA. Jul. 2023;330(1):52. https://doi.org/10.1001/jama.2023.9043.
5. Center for Disease Control and Prevention. Four in 5 pregnancy-related deaths in the U.S. are preventable: Data highlight opportunities to better protect moms, CDC Newsroom Releases. Accessed: Oct. 01, 2022. [Online]. Available: https://www.cdc.gov/media/releases/2022/p0919-pregnancy-related-deaths.html.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献